Recent Blog Posts

View Post: IPBiz: Ranbaxy wins against Roche in DNJ on valganciclovir
16 Oct 2009 by Lawrence B. Ebert  
Daiichi-Ranbaxy prevailed against Roche Palo Alto (formerly Syntex) in the District Court of New Jersey by securing a finding of noninfringement of the claims of US 6083953 directed to crystalline valganciclovir. Roche had argued that ...
View Blog: IPBiz - http://ipbiz.blogspot.com/

---

View Post: FDA Approves Valcyte(R) (valganciclovir Hydrochloride) To Prevent ...
13 Nov 2009 by skripa  
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that the US Food and Drug Administration (FDA) has approved Valcyte(R) (valganciclovir hydrochloride) for the prevention of cytomegalovirus (CMV) disease in pediatric kidney and heart ...
View Blog: Med Health News - http://mednewshealth.blogspot.com/

---

View Post: US Court rules Ranbaxy's generic valganciclovir does not infringe ...
15 Oct 2009 by Amit  
In a verdict on the patent litigation between Roche Palo Alto and the Daiichi-Ranbaxy on the former's patent rights with crystalline valganciclovir, the active ingredient in anti-viral drug Valcyte, the District Court of New Jersey has ...
View Blog: Generic Pharmaceuticals and Patents - http://genericspatent.blogspot.com/

---

View Post: IMPACT Study Showed Longer Valcyte(R) (valganciclovir ...
1 Jun 2009
CMV is the most serious viral infection affecting transplant patients ...BOSTON June 1 /- New Phase III study results pres... ...,IMPACT,Study,Showed,Longer,Valcyte(R),(valganciclovir,hydrochloride,tablets),Treatment,Demonstrated,Better ...
View Blog: Latest Medical Technology from Bio-Medicine.Org - http://www.bio-medicine.org/medicine-technology-1/

---

View Post: fda extends licensed indications of valganciclovir to paediatric ...
2 Sep 2009
the us food and drug administration (fda) has approved valganciclovir (valcyctet) for the prevention of cytomegalovirus (cmv) disease in paediatric kidney and heart transplant patients (4 months to 16 years of age) at high risk of ...
View Blog: nelm - News - http://www.nelm.nhs.uk/en/NeLM-Area/News/

---